Akeega Tablet, Film Coated
Product Images NDC 57894-050

View Photos of Packaging, Regulatory Labels, and Product Appearance

Product Visual Gallery

This gallery contains 6 technical images submitted to the FDA as part of the official labeling for Akeega (NDC 57894-050). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Janssen Biotech, Inc., these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Chemical Structure (Akeega 01)

FDA Label Image

Chemical Structure (Akeega 02)

FDA Label Image

Figure 1 (Akeega 03)

FDA Label Image

Figure 2 (Akeega 04)

FDA Label Image

Principal Display Panel (100 mg / 500 mg Bottle Carton)

Principal Display Panel (100 mg / 500 mg Bottle Carton)
This text is a description of a medication called Akeega. Each film-coated tablet of Akeega contains 100 mg of niraparib and 500 mg of abiraterone acetate. The tablets should be stored at room temperature (20°C to 25°C) with permitted excursions between 15°C and 30°C. The package is child-resistant and should be kept out of reach of children. The tablets are manufactured by Janssen Biotech, Inc. in Horsham, PA, USA, and are a product of France. The text also contains a warning that women who are or may become pregnant should not handle the tablets without protection. The tablets should not be broken, crushed, or chewed. The package contains 60 film-coated tablets.*
FDA Label Image

Principal Display Panel (50 mg / 500 mg Bottle Carton)

* These product label images have been analyzed using experimental machine learning. Please verify findings with the primary label text.